세계의 말레인산클로르페니라민 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)
Global Chlorpheniramine Maleate Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
상품코드:1820663
리서치사:Value Market Research
발행일:2025년 07월
페이지 정보:영문 133 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 말레인산클로르페니라민 시장 예측은 상당한 성장을 예측하고 있습니다. 시장 규모는 2033년까지 8억 410만 달러로 급증할 전망이며, 2024년 5억 1,479만 달러에서 크게 증가할 것으로 예측되고 있습니다. 이 확대는 2025-2033년 예상되는 5.08%라는 경이적인 연평균 성장률(CAGR)을 반영합니다.
세계의 말레인산클로르페니라민 시장은 알레르기약이나 감기약의 항히스타민제로서 널리 사용되고 있기 때문에 안정적인 성장이 예상되고 있습니다. 말레인산클로르페니라민은 재채기, 콧물, 가려움증 등의 증상을 효과적으로 완화합니다. 향후 개발은 환자의 컴플라이언스를 높이기 위한 새로운 제형, 병용 요법 및 전달 시스템의 개선에 초점을 맞출 것으로 보입니다.
또한, 알레르기성 비염 및 호흡기 질환의 유병률 상승이 시장 수요를 확대하고 있습니다. OTC의 가용성과 인지도 향상으로 소비자의 접근성도 넓어지고 있습니다. 규제 당국의 승인과 품질 기준은 제품의 안전과 효과를 형성합니다. 알레르기 치료가 진행됨에 따라, 말레인산클로르페니라민 시장은 앞으로도 혁신을 계속하여 효과적이고 안전하며 입수가능한 항히스타민제 솔루션을 제공할 것입니다.
목차
제1장 서문
제2장 주요 요약
시장의 하이라이트
세계 시장 현황
제3장 말레인산클로르페니라민 : 산업 분석
서문 : 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
업계 동향
Porter's Five Forces 분석
시장 매력 분석
제4장 밸류체인 분석
밸류체인 분석
원재료 분석
원재료 리스트
원재료 제조업체 리스트
주요 원재료의 가격 동향
잠재적 구매자 목록
마케팅 채널
직접 마케팅
간접 마케팅
마케팅 채널 발전 동향
제5장 세계의 말레인산클로르페니라민 시장 분석 : 제제 유형별
개요 : 제제 유형별
과거 및 예측 데이터 분석 : 제제 유형별
주사제
태블릿
시럽제
기타 제형 유형
제6장 세계의 말레인산클로르페니라민 시장 분석 : 용도별
개요 : 용도별
과거 및 예측 데이터 분석 : 용도별
알레르기성
알레르기성 비염(꽃가루 알레르기)
감모
기타 용도
제7장 세계의 말레인산클로르페니라민 시장 분석 : 유통 채널별
개요 : 유통 채널별
과거 및 예측 데이터 분석 : 유통 채널별
병원 약국
소매 약국
온라인 약국
제8장 세계의 말레인산클로르페니라민 시장 분석 : 지역별
지역별 전망
서문
북미의 매출 분석
개요, 분석 및 예측
북미 : 부문별
북미 국가별
미국
캐나다
멕시코
유럽의 매출 분석
개요, 분석 및 예측
유럽 : 부문별
유럽 국가별
영국
프랑스
독일
이탈리아
러시아
기타 유럽
아시아태평양의 매출 분석
개요, 분석 및 예측
아시아태평양 : 부문별
아시아태평양 국가별
중국
인도
일본
한국
호주
동남아시아
기타 아시아태평양
라틴아메리카의 매출 분석
개요, 분석 및 예측
라틴아메리카 : 부문별
라틴아메리카 국가별
브라질
아르헨티나
페루
칠레
기타 라틴아메리카
중동 및 아프리카의 매출 분석
개요, 분석 및 예측
중동 및 아프리카 : 부문별
중동 및 아프리카 국가별 일람
사우디아라비아
아랍에미리트(UAE)
이스라엘
남아프리카
기타 중동 및 아프리카
제9장 말레인산클로르페니라민 기업 경쟁 구도
말레인산클로르페니라민 시장 경쟁
제휴, 협력 및 합의
합병 및 인수
신제품 출시
기타 개발
제10장 기업 프로파일
주요 기업의 시장 점유율 분석
시장 집중도
Aden Healthcare
Alkem Laboratories
Bayer
Centaur Pharmaceuticals
Cipla
Dr. Reddy'S Laboratories
GlaxoSmithKline
Glenmark Pharmaceuticals
Merck & Co.
Montage Laboratories
Novalab Healthcare
Pfizer
Sun Pharmaceutical
AJY
영문 목차
영문목차
The forecast for the global Chlorpheniramine Maleate market predicts substantial growth, with market size projected to soar to USD 804.1 Million by 2033, a significant increase from the USD 514.79 Million recorded in 2024. This expansion reflects an impressive compound annual growth rate (CAGR) of 5.08% anticipated between 2025 and 2033.
The global chlorpheniramine maleate market is set for steady growth driven by its widespread use as an antihistamine in allergy and cold medications. Chlorpheniramine maleate effectively alleviates symptoms such as sneezing, runny nose, and itching. Future developments will focus on novel formulations, combination therapies, and improved delivery systems to enhance patient compliance.
Additionally, rising prevalence of allergic rhinitis and respiratory conditions is expanding market demand. OTC availability and growing awareness are broadening consumer access. Regulatory approvals and quality standards are shaping product safety and efficacy. As allergy treatment advances, the chlorpheniramine maleate market will continue to innovate, delivering effective, safe, and accessible antihistamine solutions.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
LIST OF SEGMENTS COVERED
This section of the Chlorpheniramine Maleate market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
3.7.1 Market Attractiveness Analysis By Formulation Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Distribution Channel
3.7.4 Market Attractiveness Analysis By Regions
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL CHLORPHENIRAMINE MALEATE MARKET ANALYSIS BY FORMULATION TYPE
5.1. Overview By Formulation Type
5.2. Historical and Forecast Data Analysis By Formulation Type
5.3. Injections Historic and Forecast Sales By Regions
5.4. Tablets Historic and Forecast Sales By Regions
5.5. Syrup Historic and Forecast Sales By Regions
5.6. Other Formulation Types Historic and Forecast Sales By Regions
6. GLOBAL CHLORPHENIRAMINE MALEATE MARKET ANALYSIS BY APPLICATION
6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Allergic Historic and Forecast Sales By Regions
6.4. Allergic Rhinitis (Hay Fever) Historic and Forecast Sales By Regions
6.5. Common Cold Historic and Forecast Sales By Regions
6.6. Other Applications Historic and Forecast Sales By Regions
7. GLOBAL CHLORPHENIRAMINE MALEATE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
7.4. Retail Pharmacies Historic and Forecast Sales By Regions
7.5. Online Pharmacies Historic and Forecast Sales By Regions
8. GLOBAL CHLORPHENIRAMINE MALEATE MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE CHLORPHENIRAMINE MALEATE COMPANIES
9.1. Chlorpheniramine Maleate Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF CHLORPHENIRAMINE MALEATE INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Aden Healthcare
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Alkem Laboratories
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Bayer
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. Centaur Pharmaceuticals
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Cipla
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Dr. Reddy'S Laboratories
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. GlaxoSmithKline
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Glenmark Pharmaceuticals
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. Merck & Co.
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
10.12. Montage Laboratories
10.12.1 Company Overview
10.12.2 Company Revenue
10.12.3 Products
10.12.4 Recent Developments
10.13. Novalab Healthcare
10.13.1 Company Overview
10.13.2 Company Revenue
10.13.3 Products
10.13.4 Recent Developments
10.14. Pfizer
10.14.1 Company Overview
10.14.2 Company Revenue
10.14.3 Products
10.14.4 Recent Developments
10.15. Sun Pharmaceutical
10.15.1 Company Overview
10.15.2 Company Revenue
10.15.3 Products
10.15.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies
